4.5 Article

Novel Baicalein-Derived Inhibitors of Plasmodium falciparum

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

Role of baicalin as a potential therapeutic agent in hepatobiliary and gastrointestinal disorders: A review

Risha Ganguly et al.

Summary: Baicalin, a natural bioactive compound derived from Scutellaria baicalensis, has broad-spectrum health benefits such as antioxidant, anticancer, anti-inflammatory, antimicrobial, cardio-protective, hepatoprotective, renal protective, and neuroprotective properties. It exhibits therapeutic potential against various hepatic disorders and has protective roles against liver and gut-associated abnormalities by modifying multiple signaling pathways. However, its low solubility and poor bioavailability pose challenges for its widespread therapeutic applications.

WORLD JOURNAL OF GASTROENTEROLOGY (2022)

Review Infectious Diseases

Protein Binding in Translational Antimicrobial Development-Focus on Interspecies Differences

Hifza Ahmed et al.

Summary: Plasma protein binding is a crucial aspect of antibiotic development and clinical use, affecting several properties of drug candidates. This review discusses the basics of plasma protein binding, including the main binding proteins, antimicrobial activity, and current role in in vitro pharmacodynamic models. Additionally, the paper evaluates the differences in plasma protein binding between different animal species and humans, as well as highlighting advanced methods for determining plasma protein binding.

ANTIBIOTICS-BASEL (2022)

Article Parasitology

Mefloquine as a prophylaxis for malaria needs to be revisited

Sundus Shafat Ahmad et al.

Summary: Malaria remains a serious global infectious disease, with Africa accounting for the highest proportion of cases. Mefloquine, commonly used for malaria prophylaxis, may lead to various neuropsychiatric side effects, especially in patients with pre-existing psychiatric disorders. Countries have updated drug labels to include warnings about these potential neuropsychiatric effects.

INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2021)

Review Pharmacology & Pharmacy

An update on the importance of plasma protein binding in drug discovery and development

Li Di

Summary: Plasma protein binding is a controversial topic in drug development, with ongoing efforts to improve the accuracy of highly bound compounds. The field continues to generate high quality data, increasing confidence in accurately measuring PPB for future predictions.

EXPERT OPINION ON DRUG DISCOVERY (2021)

Review Nutrition & Dietetics

Flavonoids as Anticancer Agents

Dalia M. Kopustinskiene et al.

NUTRIENTS (2020)

Review Pharmacology & Pharmacy

Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases

Dorothy H. J. Cheong et al.

PHARMACOLOGICAL RESEARCH (2020)

Review Pharmacology & Pharmacy

Chloroquine against malaria, cancers and viral diseases

Wenmin Zhou et al.

DRUG DISCOVERY TODAY (2020)

Review Pharmacology & Pharmacy

Pharmacokinetics and Bioavailability Enhancement of Baicalin: A Review

Ting Huang et al.

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2019)

Review Chemistry, Medicinal

Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and dengue

Pone Kamdem Boniface et al.

PHYTOTHERAPY RESEARCH (2019)

Review Pharmacology & Pharmacy

Metabolic stability and its role in the discovery of new chemical entities

Karolina Sloczynska et al.

ACTA PHARMACEUTICA (2019)

Article Cell Biology

Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase

Tanya Paquet et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Review Nutrition & Dietetics

Flavonoids: an overview

A. N. Panche et al.

JOURNAL OF NUTRITIONAL SCIENCE (2016)

Article Multidisciplinary Sciences

A novel multiple-stage antimalarial agent that inhibits protein synthesis

Beatriz Baragana et al.

NATURE (2015)

Article Cell Biology

A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria

Margaret A. Phillips et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Review Infectious Diseases

Antimalarial pharmacology and therapeutics of atovaquone

Gemma L. Nixon et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)

Article Multidisciplinary Sciences

Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery

Stephan Meister et al.

SCIENCE (2011)

Article Pharmacology & Pharmacy

Metabolic assessment in liver microsomes by co-activating cytochrome P450s and UDP-glycosyltransferases

Z Yan et al.

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2003)

Article Immunology

Chloroquine-resistant malaria

TE Wellems et al.

JOURNAL OF INFECTIOUS DISEASES (2001)